Bausch Health Cos., Inc.
(Toronto Stock Exchange : VRX)

... ...
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -1.74%26.5314.1%$156.11m
HZNPHorizon Therapeutics Plc -4.51%74.975.6%$140.10m
ACRSAclaris Therapeutics, Inc. -0.91%17.484.7%$134.73m
BHCBausch Health Cos., Inc. -1.74%26.530.0%$107.57m
CTLTCatalent, Inc. -2.08%113.322.1%$104.60m
JAZZJazz Pharmaceuticals Plc -2.88%166.052.4%$88.36m
SAVACassava Sciences, Inc. 23.92%19.430.0%$65.21m
AMRNAmarin Corp. Plc -1.06%7.481.5%$62.27m
UTHRUnited Therapeutics Corp. -2.66%164.8514.1%$60.26m
ISRIsoRay, Inc. -4.09%2.112.5%$58.22m
ACSTAcasti Pharma, Inc. -4.20%0.730.2%$55.22m
GWPHGW Pharmaceuticals Plc 4.77%150.236.1%$55.10m
PRGOPerrigo Co. Plc 0.00%44.506.8%$54.56m
ARGXargenx SE -4.55%300.990.0%$50.94m
ICPTIntercept Pharmaceuticals, Inc. 1.93%33.7816.8%$43.69m

Company Profile

Bausch Health Cos., Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products. The Bausch + Lomb/International segment consists of the sale of pharmaceutical products, over-the-counter products, and medical devices products. The Branded Rx segment comprises of pharmaceutical products related to the Salix product portfolio; dermatological product portfolio; branded pharmaceutical products, branded generic pharmaceutical products; over-the-counter products; medical device products; Bausch + Lomb products sold in Canada; and the oncology, dentistry, and health products for women. The Salix Segment consists of sales in the U.S. of GI Products, The Ortho Dermatologics segment consists of sales in the U.S. of Ortho Dermatologics (dermatological) products and global sales of Solta medical aesthetic devices. The Diversified Products segment consists of sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, in the U.S. of generic products, in the U.S. of dentistry products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.